Paper36960343
Mechanisms of macular edema.
Haydinger CD and 3 others. Front Med (Lausanne), 2023. Cited by 79 papers, by iCite.
Cite this record
ConductScience Library. Mechanisms of macular edema. Papers, record 36960343. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36960343
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References175
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21862644 | Differential expression of claudins in retinas during normal development and the angiogenesis of oxygen-induced retinopathy. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21862644 | PubMed |
| 2 | 11157879 | Diabetic macular edema: passive and active transport of fluorescein through the blood-retina barrier. | Invest Ophthalmol Vis Sci | 2001 | https://conductscience.org/library/papers/11157879 | PubMed |
| 3 | 26164736 | The Ocular Immunology and Uveitis Foundation preferred practice patterns of uveitis management. | Surv Ophthalmol | 2016 | https://conductscience.org/library/papers/26164736 | PubMed |
| 4 | 12475915 | Suppression of Fas-FasL-induced endothelial cell apoptosis prevents diabetic blood-retinal barrier breakdown in a model of streptozotocin-induced diabetes. | FASEB J | 2003 | https://conductscience.org/library/papers/12475915 | PubMed |
| 5 | 22761260 | Effects of proinflammatory cytokines on the claudin-19 rich tight junctions of human retinal pigment epithelium. | Invest Ophthalmol Vis Sci | 2012 | https://conductscience.org/library/papers/22761260 | PubMed |
| 6 | 29346240 | RESPONSE OF INFLAMMATORY CYSTOID MACULAR EDEMA TO TREATMENT USING ORAL ACETAZOLAMIDE. | Retina | 2019 | https://conductscience.org/library/papers/29346240 | PubMed |
| 7 | 20097325 | The multicenter uveitis steroid treatment trial: rationale, design, and baseline characteristics. | Am J Ophthalmol | 2010 | https://conductscience.org/library/papers/20097325 | PubMed |
| 8 | 10896339 | Inhibition of membrane-bound carbonic anhydrase decreases subretinal pH and volume. | Doc Ophthalmol | 1999 | https://conductscience.org/library/papers/10896339 | PubMed |
| 9 | 21212173 | TNFalpha is required for late BRB breakdown in diabetic retinopathy, and its inhibition prevents leukostasis and protects vessels and neurons from apoptosis. | Invest Ophthalmol Vis Sci | 2011 | https://conductscience.org/library/papers/21212173 | PubMed |
| 10 | 29580977 | Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. | Am J Ophthalmol | 2018 | https://conductscience.org/library/papers/29580977 | PubMed |
| 11 | 20381871 | Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study. | Ophthalmology | 2010 | https://conductscience.org/library/papers/20381871 | PubMed |
| 12 | 16815285 | Distinct cytokine and chemokine profiles in the aqueous of patients with uveitis and cystoid macular edema. | Am J Ophthalmol | 2006 | https://conductscience.org/library/papers/16815285 | PubMed |
| 13 | 18716950 | Optical coherence tomography for classification and clinical evaluation of macular edema in patients with uveitis. | Ocul Immunol Inflamm | 2008 | https://conductscience.org/library/papers/18716950 | PubMed |
| 14 | 9344364 | Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. | Invest Ophthalmol Vis Sci | 1997 | https://conductscience.org/library/papers/9344364 | PubMed |
| 15 | 17525153 | Evidence against functional interaction between aquaporin-4 water channels and Kir4.1 potassium channels in retinal Müller cells. | J Biol Chem | 2007 | https://conductscience.org/library/papers/17525153 | PubMed |
| 16 | 23611988 | Changes in choroidal thickness in relation to the severity of retinopathy and macular edema in type 2 diabetic patients. | Invest Ophthalmol Vis Sci | 2013 | https://conductscience.org/library/papers/23611988 | PubMed |
| 17 | 18816791 | Recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels. | J Neurosci Res | 2009 | https://conductscience.org/library/papers/18816791 | PubMed |
| 18 | 12201348 | Is acetazolamide effective in the treatment of diabetic macular edema? A pilot study. | Int Ophthalmol | 2001 | https://conductscience.org/library/papers/12201348 | PubMed |
| 19 | 16877434 | Potential role of microglia in retinal blood vessel formation. | Invest Ophthalmol Vis Sci | 2006 | https://conductscience.org/library/papers/16877434 | PubMed |
| 20 | 9726824 | Increased vascular endothelial growth factor (VEGF) and transforming growth factor beta (TGFbeta) in experimental autoimmune uveoretinitis: upregulation of VEGF without neovascularization. | J Neuroimmunol | 1998 | https://conductscience.org/library/papers/9726824 | PubMed |
Cited by62
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 79 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42923813 | Topical Carbonic Anhydrase Inhibitors in Macular Edema: A Systematic Review. | Cureus | 2026 | https://conductscience.org/library/papers/42923813 | PubMed |
| 42834336 | Insights into the modulation of age-related macular degeneration: Molecular and systems-level perspectives. | Acta Ophthalmol | 2026 | https://conductscience.org/library/papers/42834336 | PubMed |
| 42782395 | Magnitude, patterns, and determinant factors of diabetic macular edema among people with diabetes at Debre Markos Referral Hospital, Northwest Ethiopia, 2025: a hospital-based cross-sectional study. | Int Ophthalmol | 2026 | https://conductscience.org/library/papers/42782395 | PubMed |
| 42769567 | Research advances in the translational application of anti-VEGF combined with subthreshold micropulse laser therapy for refractory diabetic macular edema. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42769567 | PubMed |
| 42762026 | Incidence and Time to Onset of Pseudophakic Cystoid Macular Edema (Irvine-Gass Syndrome) After 1,325 Consecutive Cataract Surgeries Performed by a Single Surgeon Over Four Years. | Cureus | 2026 | https://conductscience.org/library/papers/42762026 | PubMed |
| 42756981 | Real-world outcomes of faricimab in treatment-naïve diabetic macular edema: The Middle East perspective. | Saudi J Ophthalmol | 2026 | https://conductscience.org/library/papers/42756981 | PubMed |
| 42662419 | Pericytes as key mediators of microenvironmental signaling crosstalk: implications in vascular diseases and cancer. | Front Cell Dev Biol | 2026 | https://conductscience.org/library/papers/42662419 | PubMed |
| 42658891 | Efficacy of a one-week course of topical bromfenac combined with corticosteroid for prevention of pseudophakic cystoid macular edema (PCME). | PLoS One | 2026 | https://conductscience.org/library/papers/42658891 | PubMed |
| 42597655 | Clinical and optical coherence tomography predictors of spontaneous resolution of diabetic macular edema: incremental value of the subfoveal large choroidal vessel layer thickness ratio. | Front Med (Lausanne) | 2026 | https://conductscience.org/library/papers/42597655 | PubMed |
| 42346829 | Blood-Ocular Barrier Dysfunction in Uveitis: A Bidirectional Model Linking Pathogenesis, Clinical Monitoring, and Therapeutic Opportunities. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42346829 | PubMed |
| 42246541 | Modulation of Systemic Osmolarity Alters Retinal Thickness and Schisis Cavities Without Blood Retinal Barrier Disruption in Rs1 Knockout Mice. | Invest Ophthalmol Vis Sci | 2026 | https://conductscience.org/library/papers/42246541 | PubMed |
| 41939430 | Efficacy and Safety of Ranibizumab Combined with Dexamethasone Intravitreal Implant Sequential Therapy for Macular Edema Secondary to Non-Ischemic Retinal Vein Occlusion. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/41939430 | PubMed |
| 41884213 | Delayed anti-vascular endothelial growth factor therapy in patients with type 2 diabetes mellitus and branch retinal vein occlusion-associated macular edema negatively affects visual outcomes. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41884213 | PubMed |
| 41835940 | Retinal hemodynamic effects of sub-Tenon anesthesia. | Front Neurosci | 2026 | https://conductscience.org/library/papers/41835940 | PubMed |
| 41827930 | The Effect of Periodontitis Severity on Diabetic Retinopathy: An Optical Coherence Tomography Study. | Diagnostics (Basel) | 2026 | https://conductscience.org/library/papers/41827930 | PubMed |
| 41821747 | A clinically actionable nomogram integrating HbA1c, renal function, and blood pressure for early prediction of diabetic macular edema in working-age patients with type 2 diabetes. | Front Endocrinol (Lausanne) | 2026 | https://conductscience.org/library/papers/41821747 | PubMed |
| 41789631 | Endothelial UNC5B regulates blood‑retinal barrier homeostasis. | Int J Mol Med | 2026 | https://conductscience.org/library/papers/41789631 | PubMed |
| 41772695 | From retina to heart: explainable machine learning using OCT and Clinical covariates for heart failure screening. | BioData Min | 2026 | https://conductscience.org/library/papers/41772695 | PubMed |
| 41710461 | Suspected Cefuroxime-Induced Cystoid Macular Edema Following Non-Toric Implantable Collamer Lens Implantation: A Case Report. | Int Med Case Rep J | 2026 | https://conductscience.org/library/papers/41710461 | PubMed |
| 41684544 | Impact of Comorbid Hypertension and Diabetes on Anti-VEGF Treatment Outcomes in Macular Edema. | J Ophthalmol | 2026 | https://conductscience.org/library/papers/41684544 | PubMed |
Genes21
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36960343
GET https://conductscience.org/api/papers/v1/36960343/references?page=2